AMXI-5001

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameAMXI-5001
Drug Alias NameAMXI-5001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin polymerisation inhibitors
TargetsTubulin
Therapy Area/IndicationsProstatic NeoplasmsOvarian NeoplasmsPancreatic Neoplasms +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAtlasMedx Incorporated
China Registration ClassN/A

Develop Information

Active CompaniesAtlasMedx Incorporated
Inactive CompaniesN/A
Active IndicationsProstatic NeoplasmsOvarian NeoplasmsPancreatic Neoplasms +[4
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A